ClinicalTrials.gov
public full text
Public Domain
The International Nocturnal Oxygen (INOX) Trial
This multicenter randomized placebo controlled trial aims to determine if in patients with COPD not qualifying for LTOT but presenting significant nocturnal arterial oxygen desaturation, whether nocturnal oxygen therapy provided for a period of 4 years decreases mortality or delay the prescription of LTOT.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Nocturnal Oxygen Therapy#846922
- Fractional Exhaled Nitric Oxide and Exacerbations of COPD#1074890
- Rehabilitation With HHFNC in COPD in Nocturnal NIV#847345
- Enhanced COPD Management in Suspected Lung Cancer Patients#851253
- A Study to Investigate the Biomarkers of Hemay005 in Adult Participants With Moderate to Severe COPD#979379
Record · ID 1173611
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive